A Salazar1, J Mañá, J M Albareda
1Servicio de Medicina Interna, Hospital de Bellvitge-Prínceps d'Espanya, Universidad de Barcelona.
Neurosarcoidosis, affecting about 5% of sarcoidosis patients, most commonly presents as cranial neuropathy. Glucocorticoid treatment is standard, with cranial nerve involvement showing a better prognosis than central nervous system disease.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science: